Delta-sleep inducing peptide entrapment in the charged macroporous matrices

One of the key challenges in peptide therapeutics is maintaining stability and achieving controlled release over time. This study by Sukhanova, Artyukhov, Gurevich, and colleagues investigated macroporous matrix entrapment as a delivery technology for Delta Sleep-Inducing Peptide (DSIP), aiming to improve its stability and release characteristics.

The researchers developed charged macroporous matrices designed to entrap DSIP and release it in a controlled manner. They characterized the entrapment efficiency, peptide stability within the matrix, and release kinetics to determine whether this delivery approach could improve DSIP's therapeutic utility.

The results demonstrated successful DSIP entrapment in the macroporous matrices with improved stability and controlled release profiles. The delivery system protected the peptide from degradation while enabling sustained release over time, addressing a critical limitation of free peptide administration.

For the development of DSIP as a sleep therapy, this delivery technology advancement is significant. The ability to provide controlled, sustained release of DSIP could lead to more effective sleep support formulations that maintain therapeutic peptide levels throughout the night, moving closer to practical clinical applications.